Lexeo Therapeutics, Inc. Common Stock
LXEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20 | -$26 | -$33 | -$26 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $3 | $4 | $0 |
| Change in WC | -$13 | -$1 | $7 | -$6 |
| Other Non-Cash | $0 | -$3 | $0 | $3 |
| Operating Cash Flow | -$30 | -$27 | -$22 | -$28 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$55 | $0 | -$94 |
| Inv. Sales/Matur. | $35 | $16 | $16 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $35 | -$39 | $16 | -$94 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | -$0 |
| Stock Issued | $0 | $80 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$7 | $0 | $0 |
| Financing Cash Flow | $0 | $73 | $0 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $6 | $7 | -$6 | -$122 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39 | $32 | $38 | $157 |
| End Cash | $44 | $39 | $32 | $35 |
| Free Cash Flow | -$30 | -$27 | -$22 | -$28 |